Back to search
Atherosclerotic Cardiovascular Disease (ASCVD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerotic Cardiovascular Disease (ASCVD) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Atherosclerotic Cardiovascular Disease (ASCVD) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronar…
This is a phase 2, double-blind, randomized, placebo-controlled, multi-center, dose-finding study to evaluate the efficacy and safety of Kylo-11 administered su…
The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovasc…
The purpose of the study CTQJ230A12304, is to evaluate the efficacy, safety, and tolerability of pelacarsen (TQJ230) compared to placebo in participants with AS…
The ULTRA-CKD trial is a prospective, randomized, open-label, multicenter trial designed to compare the efficacy and safety of moderate-intensity statin plus ez…
This non-randomized, rollover extension study will provide post-trial access to pelacarsen (TQJ230) to participants who have successfully completed either of th…
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal…
The overall objective of this pilot randomized clinical trial is to determine whether low-dose Colchicine (LoDoCo) improves vascular disease including vascular…